Tel: 1-631-626-9181 (USA)   44-207-097-1828 (Europe)

CBpromise   

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

lama3

Bookmark and Share
Official Full Name
laminin, alpha 3
Background
Laminins are basement membrane components thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. The protein encoded by this gene is the alpha-3 subunit of laminin 5, which is a complex glycoprotein composed of three subunits (alpha, beta, and gamma). Laminin 5 is thought to be involved in cell adhesion, signal transduction and differentiation of keratinocytes. Mutations in this gene have been identified as the cause of Herlitz type junctional epidermolysis bullosa. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.
Synonyms
LAMA3; laminin, alpha 3; BM600, E170, LAMNA, LOCS, lama3a; BM600 150kD subunit; epiligrin 170 kda subunit; epiligrin alpha 3 subunit; epiligrin subunit alpha; kalinin 165kD subunit; kalinin subunit alpha; laminin subunit alpha-3; laminin, alpha 3 (nicein (150kD), kalinin (165kD), BM600 (150kD), epilegrin); laminin-5 alpha 3 chain; laminin-5 subunit alpha; laminin-6 subunit alpha; laminin-7 subunit alpha; nicein 150kD subunit; nicein subunit alpha

Recent Progress

Laminin is a series of heterotrimeric proteins that contain alpha, beta and gamma subunits, assembling through a coiled domain. Laminin is the main components of basement membrane, with additional functions in tumor invasion and metastasis, along with cell migration regulation and mechanical signal transduction. In particular, The Lama3 gene codes laminin alpha3 chain which interacts with beta3 and gamma2 chains to form laminin-332, the most abundant laminin heterotrimer in the basal lamina of skin and mucosa, and is also strongly associated with cancer.

It has been indicated by genetic, clinical, and biochemical studies that to maintain the integrity of the dermal-epidermal junction, the subset of laminins that contain the chain encoded by the Lama3 gene are required. Consequently, inherited mutations or constitutive mutations in the mouse gene prevent expression of these laminins, causing junctional epidermolysis bullosa (JEB), which is a very severe and often lethal disorder characterized by detachment of the epidermis from the dermis (Fig.1). To further identify the relationship between the Lama3 gene and the disease, researchers disrupted the Lama3 gene in basal keratinocytes of adult mice, which led to the disappearance of chain-containing laminins at the dermal-epidermal junction along with formation of subepidermal blisters. The mice suffered from loss of nails, erosions on the footpads, inflammation, and development of skin fibrosis with extensive accumulation of interstitial and microfibrillar collagens. This sheds light on the possible relationship between the Lama3 gene and the disease.

Fig. 1. Junctional blisters and laminin expression in mutant skin. (C) A junctional blister present in the mutant skin that is characterized by a separation of the epidermis (e) from the dermis (d) at the BMZ. Basal cells in the lesion appear sparse and flattened (arrows). Arrows with asterisks mark cell clusters that appear undifferentiated in the superbasal cell layer. (MC Ryan et al, 2016)

While examining pedigrees of JEB patients with LAMA3 mutations, investigators observed that heterozygous carriers of functional null mutations presented subtle enamel pitting in the absence of skin fragility or other JEB symptoms. At the case report, two new LAMA3 functional null mutations were introduced: nonsense c.2377C>T p.(Arg793Ter) and splice-site c.4684+1G>A mutation which was in the heterozygous carriers exhibiting enamel pitting. It was also discovered that both parents had offspring inflicted with JEB and displayed subtle enamel pitting of secondary dentition without any sign of skin blistering. The mentioned enamel abnormality in LAMA3 mutation carriers could be attributed to a half dose effect of the laminin chain (haploinsufficiency).

Researchers also created an inducible transgenic mouse model (Lama3fl/fl/K14-Cre-ERT mouse), in which the Lama3 gene is turned off at certain time point in basal keratinocytes of the skin and mucosae. Compare to those models constantly lacking laminin-332 with early lethality, the transgenic model is viable, also allowing researchers to examine the molecular and cellular consequences caused by the loss of the laminin alpha3 chain.

Similar to the junctional epithelium, the peri-implant epithelium attaches to the surface of the implant via hemi-desmosomes (HDs) and internal basal lamina which is the extracellular matrix containing laminin332. Through layer-by-layer assembly and antibody-antigen specific binding for substrate-mediated gene transduction, researchers were able to produce a multilayer coating modified with the Lama3 on the titanium implant surface. The results in vitro indicated that the LAMA3-modified coating on the titanium surface could improve cell adhension in the early stage, and facilitate the expression of laminin α3 on both the protein and the gene levels. Also, the formation of hemidesmosomes at the interface became prominent. In vivo experiments demonstrated that the LAMA3 gene coating on the implant surface could enhance the expression of laminin α3 and improve the biological sealing between the implant and the epithelium. These findings in improving biological sealing between titanium implant and gingival epithelium offer a new approach and experimental evidence for research on the interface of the implant and soft tissues.

References:

  1. Xiao-Dong, H. U., Yang, Y. X., & Gastroenterology, D. O. (2016). “Progress of the relationship between lama3 gene and cancer”. Journal of Chinese Practical Diagnosis & Therapy.
  2. Pesch, M., König, S., & Aumailley, M. (2017). “Targeted disruption of the lama3 gene in adult mice is sufficient to induce skin inflammation and fibrosis”. Journal of Investigative Dermatology, 137(2), 332-340.
  3. Gostyńska KB, Yan Yuen W, Pasmooij AM, Stellingsma C, Pas HH, & Lemmink H, et al. (2016). “Carriers with functional null mutations in lama3 have localized enamel abnormalities due to haploinsufficiency”. European Journal of Human Genetics Ejhg, 25(1), 94.
  4. Aumailley, M., Koenig, S., Sasaki, T., & Pesch, M. (2016). “Inducible basal keratinocyte-specific knockout of the lama3 gene: a model for wound healing and fibrosis?”. Journal of Dermatological Science, 84(1), e145-e145.
  5. Zhang, J., Wang, H., Wang, Y., Dong, W., Jiang, Z., & Yang, G. (2017). “Substrate-mediated gene transduction of lama3 for promoting biological sealing between titanium surface and gingival epithelium”. Colloids & Surfaces Biointerfaces, 161, 314.